Validation of a predictive model for platelet transfusion refractoriness in patients with hematological diseases
Journal Title: Chinese Journal of Blood Transfusion - Year 2025, Vol 38, Issue 4
Abstract
[Objective] To validate and optimize the platelet transfusion refractoriness (PTR) prediction model for patients with hematological disorders established by our center. [Methods] The data of patients with hematological diseases who received platelet transfusions from December 2021 to December 2022 were used as the training set, and data from January 2023 to December 2023 as the validation set. The validation set data was used to validate the predictive model constructed on the training set. Relevant risk factors for PTR were collected through literature review and preliminary studies。 The patients were divided into effective and ineffective groups according to the corrected count increment (CCI) of platelet counts. Predictive factors were screened using univariate and multivariate logistic regression. The calibration of the model were assessed via calibration curves, while discrimination, accuracy, sensitivity, and specificity were evaluated using receiver operating characteristic (ROC) curves Clinical utility was further analyzed with decision curve analysis (DCA). [Results] The Hosmer-Lemeshow (H-L) goodness-of-fit test for the validation set yielded S: P=0.000, indicating that the original model needs optimization. Baseline comparisons and logistic regression identified the number of red blood cell units (RBCU) and platelet units (PLT-U) transfused as key predictors for the optimized model. The H-L goodness-of-fit test S: P values for the training and validation sets were 0.930 and 0.056, respectively; the ROC areas were 0.793 5 and 0.809 4, specificities 90.95% and 84.21%, sensitivities 59.26% and 70.04%, and accuracies 78.14% and 74.10%, respectively. DCA demonstrated clinical net benefit within a prediction probability threshold range of 0.2-0.8. [Conclusion] Transfusion volumes of RBC-U and PLT-U were inversely associated with PTR in hematological patients. The resulting PTR prediction model exhibits moderate predictive efficacy and clinical benefit.
Authors and Affiliations
Xiulan HUANG, Shuhan YUE, Qun CAI, Liqi LU, Mengzhen HE, Qiao LEI, Caoyi LIU, Jingwei ZHANG
Keywords
Related Articles
- EP ID EP766600
- DOI 10.13303/j.cjbt.issn.1004-549x.2025.04.012
- Views 19
- Downloads 0
Overview on haemovigilance about delayed transfusions in the UK and blood shortage in the USA
Serious hazards of transfusion(SHOT)in the United Kingdom has been received reporting of the adverse events of delayed transfusion for more than ten years. Hemovigilance Module Surveillance Protocol in Biovigilance Compo...
Effect of applied muscle tension on improving vasovagal reactions among blood donors: a meta-analysis
Objective To systematically evaluate the effect of applied muscle tension (AMT) exercises on reducing vasovagal reactions(VVRs) among blood donors by meta-analysis. Methods Nine related databases including MEDLINE, Web o...
Risk factors of allergic reactions caused by therapeutic plasma exchange: a single-center analysis
Objective To review the occurrence of allergic reactions during therapeutic plasma exchange (TPE) and to explore the risk factors of TPE allergic reactions. Methods The clinical data of 929 patients treated with TPE usin...
Exploration of the relationship between the storage time of leukodepleted red blood cell and transfusion adverse reactions
Objective To explore the relationship between the storage time of leukodepleted red blood cells and transfusion adverse reactions by analyzing the occurrence of transfusion adverse reactions of patients after leukodeplet...
Effect of preoperative anemia on perioperative red blood cell transfusion and prognosis in children with septal defect
Objective To analyze the impact of preoperative anemia on perioperative red blood cell transfusion and prognosis of children undergoing septal defect repair. Methods The medical records of 208 patients under 18 years old...